What's new? Log in Free sign up

Filing search / Lineage Cell Therapeutics, Inc. / "Waste"

Search information

Lineage Cell Therapeutics, Inc.

Companies

"Waste"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

26 results

Newest first Best match first

LCTX Lineage Cell Therapeutics, Inc.

Definitive proxy

of natural resources, pollution prevention, and reduction of waste. As climate change concerns become more prevalent, we recognize the need to comply … water usage; Supporting ethical treatment of animals in research; and Responsibly disposing of our limited waste and prioritizing responsible carbon

29 Apr 24

4:30pm

LCTX Lineage Cell Therapeutics, Inc.

the retina by metabolizing waste by-products and producing a number of components essential for photoreceptor health and function. If the metabolic … waste products accumulate, lesions known as drusen may result. Approximately 85-90% of AMD patients suffer from the dry form of AMD, for which

7 Mar 24

4:21pm

LCTX Lineage Cell Therapeutics, Inc.

Definitive proxy

environmental practices that include conservation of natural resources, pollution prevention, and reduction of waste. As climate change concerns become more … ; Reducing our water usage; Supporting ethical treatment of animals in research; and Responsibly disposing of our limited waste and prioritizing

27 Jul 23

4:05pm

LCTX Lineage Cell Therapeutics, Inc.

advances slowly toward GA in which RPE cells and photoreceptors deteriorate over time. RPE cells support and nourish the retina by metabolizing waste … by-products and producing a number of components useful for photoreceptor health and function. If the metabolic waste products accumulate, lesions

10 Mar 22

4:37pm

LCTX Lineage Cell Therapeutics, Inc.

waste by-products and producing a number of components useful for photoreceptor health and function. If the metabolic waste products accumulate, lesions

11 Mar 21

4:21pm

12 Mar 20

4:26pm

0t2bzcy5zww737r

Business combination disclosure

BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company

15 Mar 16

12:00am

11 Mar 15

12:00am

8gzfpj7xug6j563k5wvh

Regulation FD Disclosure

17 Mar 14

12:00am

hgm2ihpmfin3r 6qc4ru

17 Mar 14

12:00am

jwmwdx lpa26szxr14

Definitive proxy

22 Apr 13

12:00am

18 Mar 13

12:00am

dhxjy b1o1x4uhh

Entry into a Material Definitive Agreement

Additional proxy soliciting materials

15 Mar 11

12:00am

jyz neougxgy1im4c

15 Mar 11

12:00am

15 Mar 11

12:00am

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.